# Century Therapeutics, Inc.: filings

IPSC · Nasdaq · CIK 1850119 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ipsc.md) · [Financials](/companies/ipsc/financials.md) · [Filings](/companies/ipsc/filings.md) · [Insiders](/companies/ipsc/insiders.md)

## Reports and events: 109 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 162, 8-K 74, 144 50, 3 25, 10-Q 16, SC 13G/A 10, CORRESP 9, SC 13G 9, SCHEDULE 13G 7, UPLOAD 7, DEF 14A 6, DEFA14A 6, EFFECT 6, S-8 6, 10-K 5, S-3 5, SCHEDULE 13G/A 5, ARS 4, CERT 3, PRE 14A 3, SEC STAFF LETTER 3, 144/A 2, 424B3 2, 8-K/A 2, S-1/A 2, SC 13D/A 2, 424B4 1, 424B5 1, 424B7 1, 8-A12B 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, S-1 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 12:18 ET | [8-K](/filings/0001104659-26-113055.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113055 |
| 2026-09-09 | 20:10 ET | [8-K](/filings/0001104659-26-106312.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-106312 |
| 2026-08-12 | 12:12 ET | [8-K](/filings/0001104659-26-094533.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-094533 |
| 2026-08-12 | 12:01 ET | [10-Q](/filings/0001104659-26-094523.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094523 |
| 2026-06-16 | 20:06 ET | [8-K](/filings/0001104659-26-074577.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-074577 |
| 2026-06-12 | 20:06 ET | [8-K](/filings/0001104659-26-073429.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-073429 |
| 2026-06-08 | 20:10 ET | [8-K](/filings/0001104659-26-071383.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-071383 |
| 2026-05-13 | 12:09 ET | [8-K](/filings/0001104659-26-059824.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059824 |
| 2026-05-13 | 12:01 ET | [10-Q](/filings/0001104659-26-059816.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059816 |
| 2026-04-27 | 20:49 ET | [DEF 14A](/filings/0001104659-26-049489.md) | Proxy statement, period 2026-06-11 | 0001104659-26-049489 |
| 2026-03-26 | 20:42 ET | [8-K](/filings/0001104659-26-035256.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-035256 |
| 2026-03-12 | 12:05 ET | [8-K](/filings/0001104659-26-026761.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-026761 |
| 2026-03-12 | 12:04 ET | [10-K](/filings/0001104659-26-026759.md) | Annual report, period 2025-12-31 | 0001104659-26-026759 |
| 2026-01-23 | 21:05 ET | [8-K](/filings/0001104659-26-006236.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-26-006236 |
| 2026-01-12 | 14:05 ET | [8-K](/filings/0001104659-26-002748.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002748 |
| 2026-01-08 | 13:05 ET | [8-K](/filings/0001104659-26-001952.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-001952 |
| 2025-12-29 | 21:05 ET | [8-K](/filings/0001104659-25-124836.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-124836 |
| 2025-12-12 | 21:08 ET | [8-K](/filings/0001104659-25-120654.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-120654 |
| 2025-12-09 | 13:05 ET | [8-K](/filings/0001104659-25-119494.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-119494 |
| 2025-12-02 | 21:05 ET | [DEF 14A](/filings/0001104659-25-117704.md) | Proxy statement, period 2026-01-22 | 0001104659-25-117704 |
| 2025-11-13 | 12:52 ET | [8-K](/filings/0001104659-25-110862.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-110862 |
| 2025-11-13 | 12:35 ET | [10-Q](/filings/0001104659-25-110851.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110851 |
| 2025-08-29 | 20:10 ET | [8-K](/filings/0001104659-25-085658.md) | 3.01 Delisting notice | 0001104659-25-085658 |
| 2025-08-14 | 20:21 ET | [10-Q](/filings/0001558370-25-011575.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011575 |
| 2025-08-14 | 20:17 ET | [8-K](/filings/0001104659-25-078617.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-078617 |
| 2025-07-07 | 20:12 ET | [8-K](/filings/0001104659-25-066091.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001104659-25-066091 |
| 2025-06-16 | 21:10 ET | [8-K](/filings/0001104659-25-059950.md) | 5.07 Shareholder vote results | 0001104659-25-059950 |
| 2025-05-15 | 20:15 ET | [10-Q](/filings/0001558370-25-007885.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007885 |
| 2025-05-15 | 20:15 ET | [8-K](/filings/0001104659-25-049454.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-049454 |
| 2025-04-22 | 20:06 ET | [DEF 14A](/filings/0001104659-25-037419.md) | Proxy statement, period 2025-06-12 | 0001104659-25-037419 |
| 2025-03-19 | 20:08 ET | [8-K](/filings/0001104659-25-025559.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-025559 |
| 2025-03-19 | 20:07 ET | [10-K](/filings/0001558370-25-003299.md) | Annual report, period 2024-12-31 | 0001558370-25-003299 |
| 2025-02-28 | 21:10 ET | [8-K](/filings/0001104659-25-019145.md) | 3.01 Delisting notice | 0001104659-25-019145 |
| 2025-01-13 | 12:00 ET | [8-K](/filings/0001104659-25-002841.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002841 |
| 2024-12-13 | 22:00 ET | [8-K](/filings/0001104659-24-128491.md) | 1.02 Termination of a material agreement | 0001104659-24-128491 |
| 2024-11-05 | 14:10 ET | [8-K](/filings/0001104659-24-114136.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-114136 |
| 2024-11-05 | 14:05 ET | [10-Q](/filings/0001558370-24-014345.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014345 |
| 2024-09-26 | 11:05 ET | [8-K](/filings/0001104659-24-102988.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-102988 |
| 2024-08-08 | 11:37 ET | [8-K](/filings/0001104659-24-087013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-087013 |
| 2024-08-08 | 11:30 ET | [10-Q](/filings/0001558370-24-011467.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011467 |
| 2024-07-08 | 20:33 ET | [8-K](/filings/0001104659-24-078322.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-078322 |
| 2024-06-26 | 20:47 ET | [8-K/A](/filings/0001104659-24-075201.md) | 9.01 Financial statements and exhibits | 0001104659-24-075201 |
| 2024-06-24 | 20:26 ET | [8-K](/filings/0001104659-24-074339.md) | 5.07 Shareholder vote results | 0001104659-24-074339 |
| 2024-06-03 | 11:13 ET | [8-K](/filings/0001104659-24-067446.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067446 |
| 2024-05-09 | 11:35 ET | [8-K](/filings/0001104659-24-059124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059124 |
| 2024-05-09 | 11:30 ET | [10-Q](/filings/0001558370-24-007469.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007469 |
| 2024-04-26 | 20:08 ET | [DEF 14A](/filings/0001104659-24-052924.md) | Proxy statement, period 2024-06-20 | 0001104659-24-052924 |
| 2024-04-11 | 21:25 ET | [8-K](/filings/0001104659-24-046373.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-046373 |
| 2024-04-11 | 18:42 ET | [8-K](/filings/0001104659-24-046247.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-046247 |
| 2024-04-09 | 10:00 ET | [8-K](/filings/0001104659-24-044909.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-044909 |

Page 1 of 3. [Older](/companies/ipsc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.